Ingenane Diterpenoids from Euphorbia peplus as Potential New CHK1 Inhibitors That Sensitize Cancer Cells to

Mi Zhou1,2, Yanlan Yang1, Shoulun He1

  • 1School of Pharmaceutical Science, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen 361002, China.

PubMed

Insights

Two new compounds from Euphorbia peplus inhibit p-CHK1(S345), a key factor in chemotherapy resistance. Compound 8 enhances cancer drug efficacy by blocking this target, offering a novel therapeutic strategy.

Area of Science:

  • Natural Products Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Phosphorylation of checkpoint kinase 1 (p-CHK1(S345)) is crucial for the replication stress response in cancer, contributing to chemotherapy resistance.
  • Developing inhibitors of p-CHK1(S345) is a key strategy to overcome acquired drug resistance in cancer therapy.

Purpose of the Study:

  • To identify and characterize novel inhibitors of p-CHK1(S345) from Euphorbia peplus.
  • To investigate the structure-activity relationship (SAR) of ingenane diterpenoids against p-CHK1(S345).
  • To explore the potential of identified compounds in enhancing cancer chemotherapy sensitivity.

Main Methods:

  • Isolation and structural elucidation of 14 ingenane diterpenoids from Euphorbia peplus, including two novel compounds.
  • In vitro screening of isolated compounds for inhibitory effects on p-CHK1(S345).
  • In vivo evaluation of compound 8 in combination with topotecan.
  • Mechanistic studies involving CHK1 ubiquitination and protein kinase C (PKC) activation.

Main Results:

  • Two undescribed ingenane diterpenoids with an exocyclic double bond were identified.
  • Compounds 7 and 8 exhibited potent inhibition of p-CHK1(S345), abrogated cell cycle arrest, and increased DNA damage.
  • Compound 8 enhanced the anticancer efficacy of topotecan in vivo by blocking p-CHK1(S345).
  • Compound 8 promotes CHK1 ubiquitination and inhibits p-CHK1(S345) through PKC activation.

Conclusions:

  • Compound 8 demonstrates potential as a novel CHK1 inhibitor for cancer therapy.
  • PKC activation plays a previously unrecognized role in enhancing cancer chemotherapy sensitivity by regulating CHK1 ubiquitination.
  • This study provides a new therapeutic avenue targeting the p-CHK1(S345) pathway and PKC signaling.

Related Concept Videos

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)00:53

Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)

Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.9K
Physical Properties of Amines01:26

Physical Properties of Amines

Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
2.9K
Amines: Introduction01:07

Amines: Introduction

Amines are organic derivatives of ammonia. They are formed by replacing one or more ammonia protons with alkyl or aryl groups. Depending upon the number of organyl groups bonded to nitrogen, amines are classified as primary, secondary, or tertiary. Primary amines have one organyl group attached to the nitrogen atom, while secondary and tertiary amines have two and three organyl groups attached to the nitrogen atom, respectively.
4.1K
Nomenclature of Alkynes02:39

Nomenclature of Alkynes

Alkynes are unsaturated hydrocarbons characterized by the presence of carbon-carbon triple bonds and have a general formula CnH2n-2. The nomenclature of alkynes follows a set of rules similar to alkanes and alkenes; however, alkynes bear the suffix "-yne" instead of "-ane" or "-ene." There are two approaches to naming alkynes:
17.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K
Nomenclature of Aryl and Heterocyclic Amines01:10

Nomenclature of Aryl and Heterocyclic Amines

The simplest aromatic amine is phenylamine, which contains an –NH2 functionality directly attached to an aromatic ring. The name aniline is designated for this skeleton. As shown in Figure 1, the common names of the functionalized anilines involve prefixes ortho-, meta-, and para- to indicate the substitution position. Different functionalized aniline derivatives also have notable trivial names.
2.3K